Long-term Safety and Efficacy Study of MND-2119 in Patients With Hypertriglyceridemia

NCT04221217 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertriglyceridemia

Interventions

DRUG: Icosapent

Sponsor

Mochida Pharmaceutical Company, Ltd.